Details of the Drug
General Information of Drug (ID: DMAEHFT)
| Drug Name | 
                     O-Acetylserine 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        O-acetyl-L-serine; O-acetylserine; 5147-00-2; (S)-3-Acetoxy-2-aminopropanoic acid; O3-acetyl-L-serine; O-AC-L-Ser-OH; L-Serine, acetate (ester); acetylserine; Serine, O-acetyl-; Poly-O-acetylserine; (2S)-3-acetoxy-2-ammoniopropanoate; (2S)-3-acetoxy-2-azaniumylpropanoate; Poly-O-acetyl-L-serine; o-acetyl-serine; O-acetyl-l-ser; OAS; NSC 226230; L-Serine, O-acetyl-; bmse000983; AC1L40XB; SCHEMBL598363; AC1Q60A2; CHEBI:17981; CTK1H1469; VZXPDPZARILFQX-BYPYZUCNSA-N; MolPort-001-762-455; ZINC895446; 7170AB; ANW-60944; FCH833665
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 147.13 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -3.5 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
                    
  | 
            ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


